Krensavage Asset Management, LLC — 13F Holdings

2026 Q3  ·  21 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Krensavage Asset Management, LLC maintained a portfolio of 21 distinct positions. The most significant new addition was ANI PHARMACEUTICALS INC, now representing 0.36% of the total fund value. They heavily accumulated shares in ULTRAGENYX PHARMACEUTICAL IN, increasing the position by 191.9%. Conversely, Krensavage Asset Management, LLC completely exited their position in REGENERON PHARMACEUTICALS.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
21
Quarter
2026 Q3
Top Holding
JAZZ (14.6%)
Top 10 Concentration
88.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-21 of 21

Krensavage Asset Management, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
JAZZ
JAZZ PHARMACEUT...
Healthcare 14.64% 15.36% #1 1
Prev: #2
7.0
—
no change no change
P
S
167,816 $38,853
$116.23 +109.7%
$231.52 +5.3%
2023 Q4 13F Filing 2026-09-30 2026-11-17
ENTA
ENANTA PHARMACE...
Healthcare 14.23% 15.88% #2 1
Prev: #1
6.5
—
no change no change
P
S
2,866,138 $37,776 2015 Q1 13F Filing 2026-09-30 2026-11-17
UTHR
UNITED THERAPEU...
Healthcare 13.53% 14.26% #3
Prev: #3
5.5
—
-3,000 -4.3%
P
S
66,282 $35,918 2014 Q4 13F Filing 2026-09-30 2026-11-17
BMRN
BIOMARIN PHARMA...
Healthcare 11.86% 11.41% #4
Prev: #4
5.5
—
no change no change
P
S
524,786 $31,487 2025 Q3 13F Filing 2026-09-30 2026-11-17
ABT
ABBOTT LABORATO...
Healthcare 7.45% 6.89% #5 1
Prev: #6
4.5
—
no change no change
P
S
200,000 $19,766 2026 Q1 13F Filing 2026-09-30 2026-11-17
EXEL
EXELIXIS INC
Healthcare 6.59% 7.66% #6 1
Prev: #5
3.1
—
-71,300 -19.2%
P
S
299,393 $17,488 2021 Q3 13F Filing 2026-09-30 2026-11-17
RARE
ULTRAGENYX PHAR...
Healthcare 6.46% 4.96% #7 2
Prev: #9
5.6
—
749,988 191.9%
P
S
1,140,867 $17,147 2025 Q4 13F Filing 2026-09-30 2026-11-17
SUPN
SUPERNUS PHARMA...
Healthcare 5.69% 4.96% #8
Prev: #8
4.8
—
70,000 24.9%
P
S
350,681 $15,093 2025 Q1 13F Filing 2026-09-30 2026-11-17
SNY
SANOFI-ADR
Healthcare 5.19% 5.25% #9 2
Prev: #7
2.6
—
10,000 3.1%
P
S
333,946 $13,769 2023 Q4 13F Filing 2026-09-30 2026-11-17
EMBC
EMBECTA CORP
Healthcare 2.42% 1.41% #10 5
Prev: #15
2.0
—
no change no change
P
S
1,135,340 $6,426 2022 Q2 13F Filing 2026-09-30 2026-11-17
ARDX
ARDELYX INC
Healthcare 2.34% 1.04% #11 5
Prev: #16
3.9
—
1,280,969 239.6%
P
S
1,815,492 $6,209 2026 Q1 13F Filing 2026-09-30 2026-11-17
BNTX
BIONTECH SE-ADR
Healthcare 2.20% 2.10% #12 1
Prev: #11
1.9
—
no change no change
P
S
59,523 $5,851 2024 Q1 13F Filing 2026-09-30 2026-11-17
VNDA
VANDA PHARMACEU...
Healthcare 2.18% 2.74% #13 3
Prev: #10
1.9
—
no change no change
P
S
1,180,388 $5,796 2022 Q3 13F Filing 2026-09-30 2026-11-17
GSK
GSK PLC-SPON AD...
Healthcare 1.76% 1.93% #14 2
Prev: #12
1.7
—
no change no change
P
S
96,729 $4,659 2025 Q1 13F Filing 2026-09-30 2026-11-17
BIIB
BIOGEN INC
Healthcare 1.70% 1.64% #15 2
Prev: #13
1.7
—
no change no change
P
S
20,000 $4,518 2019 Q1 13F Filing 2026-09-30 2026-11-17
INMD
INMODE LTD
Healthcare 0.65% 0.67% #16 1
Prev: #17
1.3
—
no change no change
P
S
120,942 $1,714 2026 Q1 13F Filing 2026-09-30 2026-11-17
ANIP
ANI PHARMACEUTI...
Healthcare 0.36% — #17
Prev: #—
3.6
—
13,000 —
NEW
13,000 $944 2026 Q3 13F Filing 2026-09-30 2026-11-17
ACAD
ACADIA PHARMACE...
Healthcare 0.30% — #18
Prev: #—
3.6
—
40,000 —
NEW
40,000 $806 2026 Q3 13F Filing 2026-09-30 2026-11-17
ZTS
ZOETIS INC
Healthcare 0.26% — #19
Prev: #—
3.6
—
10,000 —
NEW
10,000 $698 2026 Q3 13F Filing 2026-09-30 2026-11-17
EOLS
EVOLUS INC
Healthcare 0.17% 0.42% #20 2
Prev: #18
0.1
—
-100,000 -63.3%
P
S
57,985 $464 2025 Q3 13F Filing 2026-09-30 2026-11-17
REGN
REGENERON PHARM...
Healthcare 0.00% 1.42%
Sold All 😨
(Was: #14)
0.0
—
-6,000 -100.0%
CLOSED
— $— 2019 Q4 13F Filing 2026-09-30 2026-11-17
Showing 1-21 of 21 holdings

Unlock Full Krensavage Asset Management, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →